Management of diffuse pontine gliomas in children: recent developments (Q34347540)

1 August 2017

title

Management of diffuse pontine gliomas in children: recent developments (English)

1 reference

1 August 2017

Rejin Kebudi

1

1 reference

1 August 2017

Fatma Betul Cakir

series ordinal

2

1 reference

1 August 2017

publication date

1 October 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

351-362

1 reference

Epidemiology of glial and non-glial brain tumours in Europe

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Pediatric brain stem gliomas: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Treatment options in childhood pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Pediatric diffuse intrinsic pontine glioma patients from a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Bevacizumab in recurrent high-grade pediatric gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Potential role for valproate in the treatment of high--risk brain tumors of childhood-results from a retrospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Aurora kinase inhibitors--rising stars in cancer therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Aurora kinase B is a potential therapeutic target in pediatric diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Clinical results of BNCT for malignant brain tumors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: A phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-013-0033-5

Aurora kinase inhibitors in preclinical and clinical testing

21 January 2018

1 reference

12 December 2020

Brain tumors in children

1 reference

12 December 2020

Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group

1 reference

12 December 2020

Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours

1 reference

12 December 2020

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma

1 reference

12 December 2020

Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view

1 reference

12 December 2020

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

1 reference

12 December 2020

Influence of valproic acid on outcome of high-grade gliomas in children.

1 reference

12 December 2020

10.1007/S40272-013-0033-5

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1021156247

0 references

1 reference